Key Market Indicators
Greece is set to be the tenth-largest market for digestive system disorder medicine, with sales reaching around $1.1 billion by 2026. The country's market has grown by an average of around 3.8% year-on-year since 1995. This year, Australia overtook Greece, with digestive system disorder medicine sales of $997.3 million, while Japan, South Korea and Canada rank second, third and fourth, respectively.